Home LiteratureArticle Details
PMID: 16847068 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection.

The Journal of experimental medicine ·Vol. 203 ·No. 8 ·2006-08-07 ·Pages 1963-75

Lauterbach H, Zuniga EI, Truong P, Oldstone MB, McGavern DB

Abstract

Given the global impact of persistent infections on the human population, it is of the utmost importance to devise strategies to noncytopathically purge tissues of infectious agents. The central nervous system (CNS) poses a unique challenge when considering such strategies, as it is an immunologically specialized compartment that contains a nonreplicative cell population. Administration of exogenously derived pathogen-specific memory T cells (referred to as adoptive immunotherapy) to mice burdened with a persistent lymphocytic choriomeningitis virus (LCMV) infection from birth results in eradication of the pathogen from all tissues, including the CNS. In this study, we sought mechanistic insights into this highly successful therapeutic approach. By monitoring the migration of traceable LCMV-specific memory CD8+ T cells after immunotherapy, it was revealed that cytotoxic T lymphocytes (CTLs) distributed widely throughout the CNS compartment early after immunotherapy, which resulted in a dramatic elevation in the activity of CNS antigen-presenting cells (APCs). Immunotherapy induced microglia activation as well as the recruitment of macrophages and dendritic cells (DCs) into the brain parenchyma. However, DCs emerged as the only CNS APC population capable of inducing memory CTLs to preferentially produce the antiviral cytokine tumor necrosis factor-alpha, a cytokine demonstrated to be required for successful immunotherapeutic clearance. DCs were also found to be an essential element of the immunotherapeutic process because in their absence, memory T cells failed to undergo secondary expansion, and viral clearance was not attained in the CNS. These experiments underscore the importance of DCs in the immunotherapeutic clearance of a persistent viral infection and suggest that strategies to elevate the activation/migration of DCs (especially within the CNS) may facilitate pathogen clearance.

MeSH Terms
Animals Animals, Newborn Antigen Presentation/immunology Brain/cytology,pathology,virology Carrier State Cell Movement Dendritic Cells/cytology,immunology,virology Histocompatibility Antigens Class II/metabolism Humans Immunologic Memory/immunology Immunotherapy, Adoptive Kinetics Lymphocytic Choriomeningitis/immunology Lymphocytic choriomeningitis virus/physiology Mice Mice, Inbred C57BL Spleen/cytology T-Lymphocytes/immunology Tumor Necrosis Factor-alpha/metabolism
Chemicals
Histocompatibility Antigens Class II Tumor Necrosis Factor-alpha
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Lauterbach Henning
Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA 92037, USA.
Zuniga Elina I
Truong Phi
Oldstone Michael B A
McGavern Dorian B
References (42)
42 references, click to expand
  1. Molecular anatomy of antigen-specific CD8(+) T cell engagement and synapse formation in vivo.
    Nat Immunol. 2002 Oct;3(10):918-25 PMID: 12352968
  2. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.
    Immunity. 2002 Aug;17(2):211-20 PMID: 12196292
  3. Molecular and functional profiling of memory CD8 T cell differentiation.
    Cell. 2002 Dec 13;111(6):837-51 PMID: 12526810
  4. Three or more routes for leukocyte migration into the central nervous system.
    Nat Rev Immunol. 2003 Jul;3(7):569-81 PMID: 12876559
  5. Myeloid marker expression on antiviral CD8+ T cells following an acute virus infection.
    Eur J Immunol. 2003 Oct;33(10):2736-43 PMID: 14515257
  6. Visualizing the viral burden: phenotypic and functional alterations of T cells and APCs during persistent infection.
    J Immunol. 2004 May 15;172(10):6239-50 PMID: 15128812
  7. Initiation of immune responses in brain is promoted by local dendritic cells.
    J Immunol. 2004 Aug 15;173(4):2353-61 PMID: 15294948
  8. Rebuilding an immune-mediated central nervous system disease: weighing the pathogenicity of antigen-specific versus bystander T cells.
    J Immunol. 2004 Oct 15;173(8):4779-90 PMID: 15470017
  9. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains.
    J Gen Virol. 1983 Aug;64 (Pt 8):1689-98 PMID: 6875516
  10. Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system.
    Nature. 1986 May 15-21;321(6067):239-43 PMID: 3086743
  11. Immunotherapy for virus infection.
    Curr Top Microbiol Immunol. 1987;134:211-29 PMID: 3495409
  12. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen.
    Nature. 1989 Nov 30;342(6249):559-61 PMID: 2573841
  13. Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo.
    J Gen Virol. 1989 Dec;70 ( Pt 12):3317-25 PMID: 2514255
  14. High resolution in situ hybridization to determine the cellular distribution of lymphocytic choriomeningitis virus RNA in the tissues of persistently infected mice: relevance to arenavirus disease and mechanisms of viral persistence.
    J Gen Virol. 1991 Jul;72 ( Pt 7):1611-25 PMID: 1649899
  15. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system.
    Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7438-42 PMID: 1651506
  16. Viral persistence in neurons explained by lack of major histocompatibility class I expression.
    Science. 1991 Sep 13;253(5025):1283-5 PMID: 1891717
  17. Neuronal cells are deficient in loading peptides onto MHC class I molecules.
    Neuron. 1992 Jun;8(6):1185-90 PMID: 1610569
  18. Replication of lymphocytic choriomeningitis virus is restricted in terminally differentiated neurons.
    J Virol. 1993 Dec;67(12):7350-9 PMID: 8230458
  19. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared.
    J Immunol. 1995 May 1;154(9):4309-21 PMID: 7722289
  20. An essential role for type 1 interferon-gamma in terminating persistent viral infection.
    Virology. 1995 Sep 10;212(1):244-50 PMID: 7676639
  21. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system.
    Neuroscience. 1996 Sep;74(2):599-608 PMID: 8865208
  22. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.
    Immunity. 1998 Feb;8(2):177-87 PMID: 9491999
  23. CD11c (leukocyte integrin CR4 alpha subunit).
    J Biol Regul Homeost Agents. 1999 Apr-Jun;13(2):134-6 PMID: 10503738
  24. Studies on immunological tolerance to LCM virus. A preliminary report on adoptive immunization of virus carrier mice.
    Acta Pathol Microbiol Scand. 1962;56:305-10 PMID: 13997775
  25. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
    Nat Med. 2005 Mar;11(3):335-9 PMID: 15735651
  26. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.
    Nat Med. 2005 Mar;11(3):328-34 PMID: 15735653
  27. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma.
    J Exp Med. 2005 Mar 21;201(6):981-91 PMID: 15781587
  28. Dendritic cells maximize the memory CD8 T cell response to infection.
    Immunity. 2005 May;22(5):561-70 PMID: 15894274
  29. Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers.
    J Immunol. 2000 Jan 1;164(1):208-16 PMID: 10605013
  30. Defining parameters for successful immunocytotherapy of persistent viral infection.
    Virology. 2000 Jan 20;266(2):257-63 PMID: 10639312
  31. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells.
    Clin Exp Immunol. 2005 Sep;141(3):398-404 PMID: 16045728
  32. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection.
    J Virol. 2005 Aug;79(16):10514-27 PMID: 16051844
  33. Vaccination to treat persistent viral infection.
    Virology. 2000 Mar 15;268(2):411-9 PMID: 10704349
  34. Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii.
    J Immunol. 2000 May 1;164(9):4826-34 PMID: 10779791
  35. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis.
    Am J Pathol. 2000 Dec;157(6):1991-2002 PMID: 11106572
  36. Brain dendritic cells and macrophages/microglia in central nervous system inflammation.
    J Immunol. 2001 Feb 15;166(4):2717-26 PMID: 11160337
  37. Noncytolytic control of viral infections by the innate and adaptive immune response.
    Annu Rev Immunol. 2001;19:65-91 PMID: 11244031
  38. Developmental plasticity of CNS microglia.
    Proc Natl Acad Sci U S A. 2001 May 22;98(11):6295-300 PMID: 11371643
  39. Mouse and human dendritic cell subtypes.
    Nat Rev Immunol. 2002 Mar;2(3):151-61 PMID: 11913066
  40. Immunocytotherapy.
    Curr Top Microbiol Immunol. 2002;263:43-65 PMID: 11987819
  41. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain.
    J Neuroimmunol. 2002 Aug;129(1-2):125-32 PMID: 12161028
  42. T cells in the central nervous system: the delicate balance between viral clearance and disease.
    J Infect Dis. 2002 Dec 1;186 Suppl 2:S145-51 PMID: 12424690
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2006-08-07
Epub
2006-00-17
Pages
1963-75
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118382
Subset
IM
Grants
NIAID NIH HHS · R01 AI045927 · United States
NIAID NIH HHS · AI09484 · United States
NIAID NIH HHS · R01 AI009484 · United States
NINDS NIH HHS · R21 NS048866 · United States
NINDS NIH HHS · NS048866-01 · United States
NIAID NIH HHS · AI045927 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com